Here is the @asco statement: https://t.co/WKKudtZRSi
RT @ASCO: Read our provisional clinical opinion on evaluating susceptibility to #pancreaticcancer ➡️ https://t.co/T7kQebUA4t #GI20 #pancsm
RT @ASCO: Read our provisional clinical opinion on evaluating susceptibility to #pancreaticcancer ➡️ https://t.co/T7kQebUA4t #GI20 #pancsm
RT @ASCO: Read our provisional clinical opinion on evaluating susceptibility to #pancreaticcancer ➡️ https://t.co/T7kQebUA4t #GI20 #pancsm
RT @ASCO: Read our provisional clinical opinion on evaluating susceptibility to #pancreaticcancer ➡️ https://t.co/T7kQebUA4t #GI20 #pancsm
RT @ASCO: Read our provisional clinical opinion on evaluating susceptibility to #pancreaticcancer ➡️ https://t.co/T7kQebUA4t #GI20 #pancsm
RT @ASCO: Read our provisional clinical opinion on evaluating susceptibility to #pancreaticcancer ➡️ https://t.co/T7kQebUA4t #GI20 #pancsm…
Read our provisional clinical opinion on evaluating susceptibility to #pancreaticcancer ➡️ https://t.co/T7kQebUA4t #GI20 #pancsm
RT @aakonc: @gabe_a_brooks @DrR_DUNNE @loconte @ShaalanBeg @MPishvaian @mdmanishshah Yes already recommended by this @ASCO @JCO_ASCO guidel…
RT @aakonc: @gabe_a_brooks @DrR_DUNNE @loconte @ShaalanBeg @MPishvaian @mdmanishshah Yes already recommended by this @ASCO @JCO_ASCO guidel…
@gabe_a_brooks @DrR_DUNNE @loconte @ShaalanBeg @MPishvaian @mdmanishshah Yes already recommended by this @ASCO @JCO_ASCO guideline https://t.co/OLhTvBAHHD
RT @MattYurgelun: Yes! Regardless of family history or age at diagnosis. Recent @ASCO Provisional Clinical Opinion made very similar statem…
RT @MattYurgelun: Yes! Regardless of family history or age at diagnosis. Recent @ASCO Provisional Clinical Opinion made very similar statem…
RT @MattYurgelun: Yes! Regardless of family history or age at diagnosis. Recent @ASCO Provisional Clinical Opinion made very similar statem…
RT @MattYurgelun: Yes! Regardless of family history or age at diagnosis. Recent @ASCO Provisional Clinical Opinion made very similar statem…
RT @MattYurgelun: Yes! Regardless of family history or age at diagnosis. Recent @ASCO Provisional Clinical Opinion made very similar statem…
Yes! Regardless of family history or age at diagnosis. Recent @ASCO Provisional Clinical Opinion made very similar statement #PancChat https://t.co/Jo1ZvC1JuN
Dr. Matthew Yurgelun @HaleCenter_DFCI researcher @DanaFarber coauthored a paper on evaluation of susceptibility to #PancreaticCancer https://t.co/KPqCZLu79o
RT @marklewismd: From @JCO_ASCO do not miss the opportunity to identify hereditary predisposition in patients with pancreatic adenocarcinom…
RT @marklewismd: From @JCO_ASCO do not miss the opportunity to identify hereditary predisposition in patients with pancreatic adenocarcinom…
RT @marklewismd: From @JCO_ASCO do not miss the opportunity to identify hereditary predisposition in patients with pancreatic adenocarcinom…
RT @marklewismd: From @JCO_ASCO do not miss the opportunity to identify hereditary predisposition in patients with pancreatic adenocarcinom…
RT @marklewismd: From @JCO_ASCO do not miss the opportunity to identify hereditary predisposition in patients with pancreatic adenocarcinom…
RT @marklewismd: From @JCO_ASCO do not miss the opportunity to identify hereditary predisposition in patients with pancreatic adenocarcinom…
From @JCO_ASCO do not miss the opportunity to identify hereditary predisposition in patients with pancreatic adenocarcinoma #pancsm #GI19 https://t.co/pm00k34wQJ
BRCA, MSI-H and many other germline mutations are found in #pancreaticcancer. Can have major impact on patients/families. Great guideline update. #pancchat
Late to this, but our @ASCO panel recently provided new recs re hereditary testing essentially expanding to all pancreas cancer pts regardless of fam hx w/E Stoffel, @MattYurgelun many others #PancChat https://t.co/OLhTvBAHHD
RT @JuanjoReinaZ: Ya aparecen las primeras revisiones sistemáticas sobre consejo genético en adenocarcinoma de pancreas: Evaluating Suscept…
Ya aparecen las primeras revisiones sistemáticas sobre consejo genético en adenocarcinoma de pancreas: Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion: Journal of Clinical Oncology: Vol 37, No 2 https://t.co/u6qm4E0KUQ
RT @hanacoppy: JCOから、家族性膵癌を見逃すなという話。 夏のJSMOのシンポジウムで、確率は低くても結果が重大なので、膵癌全員にgerm lineの遺伝子検査が推奨されるようになるみたいな話を聞いたけど、そういう話。 でもわかってても早期発見が難しいのに実際ど…
RT @hanacoppy: JCOから、家族性膵癌を見逃すなという話。 夏のJSMOのシンポジウムで、確率は低くても結果が重大なので、膵癌全員にgerm lineの遺伝子検査が推奨されるようになるみたいな話を聞いたけど、そういう話。 でもわかってても早期発見が難しいのに実際ど…
RT @hanacoppy: JCOから、家族性膵癌を見逃すなという話。 夏のJSMOのシンポジウムで、確率は低くても結果が重大なので、膵癌全員にgerm lineの遺伝子検査が推奨されるようになるみたいな話を聞いたけど、そういう話。 でもわかってても早期発見が難しいのに実際ど…
RT @hanacoppy: JCOから、家族性膵癌を見逃すなという話。 夏のJSMOのシンポジウムで、確率は低くても結果が重大なので、膵癌全員にgerm lineの遺伝子検査が推奨されるようになるみたいな話を聞いたけど、そういう話。 でもわかってても早期発見が難しいのに実際ど…
RT @hanacoppy: JCOから、家族性膵癌を見逃すなという話。 夏のJSMOのシンポジウムで、確率は低くても結果が重大なので、膵癌全員にgerm lineの遺伝子検査が推奨されるようになるみたいな話を聞いたけど、そういう話。 でもわかってても早期発見が難しいのに実際ど…
RT @hanacoppy: JCOから、家族性膵癌を見逃すなという話。 夏のJSMOのシンポジウムで、確率は低くても結果が重大なので、膵癌全員にgerm lineの遺伝子検査が推奨されるようになるみたいな話を聞いたけど、そういう話。 でもわかってても早期発見が難しいのに実際ど…
RT @hanacoppy: JCOから、家族性膵癌を見逃すなという話。 夏のJSMOのシンポジウムで、確率は低くても結果が重大なので、膵癌全員にgerm lineの遺伝子検査が推奨されるようになるみたいな話を聞いたけど、そういう話。 でもわかってても早期発見が難しいのに実際ど…
RT @hanacoppy: JCOから、家族性膵癌を見逃すなという話。 夏のJSMOのシンポジウムで、確率は低くても結果が重大なので、膵癌全員にgerm lineの遺伝子検査が推奨されるようになるみたいな話を聞いたけど、そういう話。 でもわかってても早期発見が難しいのに実際ど…
RT @hanacoppy: JCOから、家族性膵癌を見逃すなという話。 夏のJSMOのシンポジウムで、確率は低くても結果が重大なので、膵癌全員にgerm lineの遺伝子検査が推奨されるようになるみたいな話を聞いたけど、そういう話。 でもわかってても早期発見が難しいのに実際ど…
JCOから、家族性膵癌を見逃すなという話。 夏のJSMOのシンポジウムで、確率は低くても結果が重大なので、膵癌全員にgerm lineの遺伝子検査が推奨されるようになるみたいな話を聞いたけど、そういう話。 でもわかってても早期発見が難しいのに実際どうするんだろうね。。。 https://t.co/d9NmRZ78Eg
Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion. https://t.co/38nAEAUaJI via @CDC.gov
Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion https://t.co/l0Xga5zUwB #cancer
RT @JCO_ASCO: Evaluating susceptibility to pancreatic cancer - an @ASCO provisional clinical opinion https://t.co/yZsNASpwsX #pancsm https:…
RT @cancerassassin1: #Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion: @ASCO consensus panel, @JCO_ASCO h…
RT @JCO_ASCO: Evaluating susceptibility to pancreatic cancer - an @ASCO provisional clinical opinion https://t.co/yZsNASpwsX #pancsm https:…
RT @JCO_ASCO: Evaluating susceptibility to pancreatic cancer - an @ASCO provisional clinical opinion https://t.co/yZsNASpwsX #pancsm https:…
RT @JCO_ASCO: Evaluating susceptibility to pancreatic cancer - an @ASCO provisional clinical opinion https://t.co/yZsNASpwsX #pancsm https:…
Evaluating susceptibility to pancreatic cancer - an @ASCO provisional clinical opinion https://t.co/yZsNASpwsX #pancsm https://t.co/msSgldTEoT
#Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion: @ASCO consensus panel, @JCO_ASCO https://t.co/fqczVnhFXS @aakonc #pancsm #pancreaticcancer #PancreaticCancerAwarenessMonth